Article
Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.
Clinical lung cancer - 1 Jan 2014
Tan Xiaoming, Wu Qihan, Cai Yanyan, Zhao Xueying, Wang Shingming, Gao Zhiqiang, Yang Yang, Li Xiaoying, Qian Ji, Wang Jiucun, Su Bo, Chen Hongyan, Han Baohui, Jiang Gening, Lu Daru
Abstract excerpt
BACKGROUND: Platinum-based chemotherapy regimens can cause DNA damage. Macrophage migration inhibitory factor (MIF) plays an important role in the regulation of the cell cycle by either controlling the activity of the SKP1-Cullin/Cdc53-F-box protein ubiquitin ligase (SCF) complex or activating its receptor, CD74. PATIENTS AND METHODS: We used a pathway-based approach to investigate the association between genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
